🏦FDIC's Proposed Rule Changes for Digital Signage Requirements
The Federal Deposit Insurance Corporation (FDIC) is seeking comment on a proposal that would amend signage requirements for insured depository institutions' (IDIs) digital deposit-taking channels and automated teller machines (ATMs) and like devices. The proposed changes are intended to address implementation issues and sources of potential confusion that have arisen following the adoption of current signage requirements for these banking channels. The proposal would provide additional flexibility to IDIs while also enabling consumers to better understand when they are conducting business with an IDI and when their funds are protected by the FDIC's deposit insurance coverage.
Learn More🏺Notice of Inventory Completion by Kansas State Historical Society
In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the Kansas State Historical Society (KSHS) has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes or Native Hawaiian organizations in this notice.
Learn More💊Cambrex Applies for Controlled Substances Import Registration
Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💵ICC Application for Clearing Agency Registration Under SEC
The Securities and Exchange Commission is reviewing an application from ICE Clear Credit LLC to register as a clearing agency for U.S. Treasury securities. This application outlines ICC’s proposed operational structure, risk management strategies, and the establishment of a Treasury Guaranty Fund, inviting public comment on the regulatory implications for market participants.
Learn More🧬FDA Classifies Cancer Predisposition Risk Assessment Systems
The Food and Drug Administration (FDA, the Agency, or we) is classifying the cancer predisposition risk assessment system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the cancer predisposition risk assessment system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More💊Catalent CTS, LLC DEA Importer Application Overview
Catalent CTS, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More📈SEC Notice on CoinShares XRP ETF Listing Review Extension
The SEC issued a notice regarding the proposed rule change by Nasdaq to list and trade shares of the CoinShares XRP ETF. This follows the agency's decision to extend the review period for that proposal, allowing more time for consideration of related issues before a final decision is made.
Learn More🌬️EPA Proposes Redesignation of Muscatine, IA Air Quality Status
The Environmental Protection Agency (EPA) is proposing to redesignate the nonattainment area in Muscatine County, Iowa to attainment for the 2010 1-hour sulfur dioxide (SO<INF>2</INF>) National Ambient Air Quality Standard (NAAQS). The EPA is also proposing to approve Iowa's maintenance plan for the 2010 1-hour SO<INF>2</INF> NAAQS for the Muscatine nonattainment area and approve modifications to source-specific permits in the Iowa State Implementation Plan (SIP). The EPA's proposed approval of this rule revision is being done in accordance with the requirements of the Clean Air Act (CAA).
Learn More🧪FDA Classifies Menopause Test System Under Class II Regulations
The Food and Drug Administration (FDA, Agency, or we) is classifying the menopause test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the menopause test system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More🩺FDA Classifies Device for Detecting Vaginitis-Related Microorganisms
The Food and Drug Administration (FDA, the Agency, or we) is classifying the device that detects nucleic acid sequences from microorganisms associated with vaginitis and bacterial vaginosis into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the device that detects nucleic acid sequences from microorganisms associated with vaginitis and bacterial vaginosis's classification. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Learn More